Cytokine Genotyping in Preeclampsia
暂无分享,去创建一个
R. Mattar | S. Daher | N. Sass | Rosiane Mattar | Silvia Daher | Nelson Sass | Leandro G Oliveira | L. Oliveira
[1] L. Hefler,et al. Transforming growth factor‐beta 1 serum levels in pregnancy and pre‐eclampsia , 2002, Acta obstetricia et gynecologica Scandinavica.
[2] J. Martin,et al. Expression of the placental cytokines tumor necrosis factor α, interleukin 1β, and interleukin 10 is increased in preeclampsia ☆ ☆☆ ★ , 1999 .
[3] B. Sibai,et al. Lack of association of severe preeclampsia with maternal and fetal mutant alleles for tumor necrosis factor α and lymphotoxin α genes and plasma tumor necrosis factor α levels , 2001 .
[4] G. Chen,et al. Tumour necrosis factor‐alpha (TNF‐α) gene polymorphism and expression in pre‐eclampsia , 1996 .
[5] S. Brennecke,et al. Association of the TNF2 Allele with Eclampsia , 2004, Gynecologic and Obstetric Investigation.
[6] K. Ward,et al. A promoter mutation in the tumor necrosis factor α gene is not associated with preeclampsia , 1998 .
[7] M. Laakso,et al. Tumour necrosis factor-α gene haplotype is associated with pre-eclampsia , 2005 .
[8] D. Darmochwal-Kolarz,et al. T helper 1- and T helper 2-type cytokine imbalance in pregnant women with pre-eclampsia. , 1999, European journal of obstetrics, gynecology, and reproductive biology.
[9] U. Göhring,et al. Preeclamptic women are deficient of interleukin-10 as assessed by cytokine release of trophoblast cells in vitro. , 2003, Cytokine.
[10] A. Hajeer,et al. In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. , 1999, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.
[11] M. Shaarawy,et al. Maternal Serum Transforming Growth Factor Beta-2 in Preeclampsia and Eclampsia, a Potential Biomarker for the Assessment of Disease Severity and Fetal Outcome , 2001, The Journal of the Society for Gynecologic Investigation: JSGI.
[12] R. Mattar,et al. Cytokines in recurrent pregnancy loss. , 2004, Journal of reproductive immunology.
[13] L. Cherry,et al. Short- and Long-Term Changes in Plasma Inflammatory Markers Associated With Preeclampsia , 2004, Hypertension.
[14] D. Harlan,et al. ASSOCIATION OF CYTOKINE POLYMORPHIC INHERITANCE AND IN VITRO CYTOKINE PRODUCTION IN ANTI-CD3/CD28-STIMULATED PERIPHERAL BLOOD LYMPHOCYTES1 , 2001, Transplantation.
[15] Jianfeng Xu,et al. Racial differences in selected cytokine allelic and genotypic frequencies among healthy, pregnant women in North Carolina. , 2003, Cytokine.
[16] F. Pociot,et al. Cytokine gene polymorphism in human disease: on-line databases , 1999, Genes and Immunity.
[17] R. Bertina,et al. Interleukin 10-2849AA genotype protects against pre-eclampsia , 2004, Genes and Immunity.
[18] J. N. Martin,et al. Expression of the placental cytokines tumor necrosis factor alpha, interleukin 1beta, and interleukin 10 is increased in preeclampsia. , 1999, American journal of obstetrics and gynecology.
[19] F. Pociot,et al. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles , 1993, The Journal of experimental medicine.
[20] M. Lazarus,et al. An investigation of polymorphism in the interleukin-10 gene promoter. , 1997, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.
[21] W. Hop,et al. Are cytokine gene polymorphisms related to in vitro cytokine production profiles? , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.